Skip to main content
OpenTrials
Completed

NCT Number: NCT01139671

Comparison of Sufentanil and Remifentanil Infusion During General Anaesthesia for Removal of Wisdom Teeth in Ambulatory Surgery

Wisdom teeth removal under general anaesthesia is usually suitable for ambulatory surgery.

The choice of opioid in dental day surgery is based on the need for a rapid and full recovery, as well as less morphine administration. Whether remifentanil can achieve these goals remains to be proved, especially regarding remifentanil-induced hyperalgesia, the potential prolonged Post Anesthesia Care Unit (PACU) stay, or remifentanil-induced workload for nurses.

Completed

Looking for future studies?

Notify Me

Key information

Age range

15 year–35 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 4

Primary location

CHU Clermont-Ferrand

Clermont-Ferrand, 63003, France

About this study

Patients will be enrolled during the preoperative anaesthetic assessment. Premedication will be achieved with oral administration of hydroxyzine 1 mg/kg the morning before surgery.

The induction of general anaesthesia will be achieved using TARGET CONTROLLED INFUSION (TCI) of propofol associated to TCI of remifentanil or sufentanil, depending on randomization.

The conditions of endotracheal intubation will be evaluated by the Percentage Of Glottic Opening Score (POGO) and the Cormack and Lehane Score.

Mechanical volume-controled ventilation will aim to maintain normocapnia. The baseline inspiratory gas will be a mixture of 45% oxygen and 55% nitrous oxide.

Bispectral Index recording and vital signs monitoring (heart rate and arterial blood pressure) will be used to monitor the depth of anaesthesia.

Dexamethasone 0.3 mg/kg will be administered after induction of general anaesthesia as part of our routine practice.

Patients will be extubated as soon as possible after the end of the surgery and transferred to the PACU.

Nurses in charge patients included in the study will be blinded to the opiod agent administered peroperatively.

Postoperative pain will be assessed using the simple numeric scale. A pain score above 3/10 will prompt the intravenous administration of titrated morphine chlorhydrate, as guided by a written protocol.

Patient will be transferred from the PACU to the ambulatory surgery unit when the Aldrete score is greater or equal to 9. Every patient included will received 1 gr of intravenous paracetamol two hours after the arrival hour in the PACU.

Pain monitoring will be continued in the ambulatory surgery unit, and morphine chlorhydrate will be orally administered (10 mg) if pain score is above 3/10.

Post anaesthetic discharge for home readiness will be given when the Post Anesthetic Discharge Scoring System (PADSS) is greater or equal to 9.

48 hours after the surgery, one of us, blinded to the opiod agent received by the patient, will contact every included patient by phone, in order to evaluate postoperative pain, potential side effects including nausea and vomiting, and patient satisfaction.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • -age between 15 and 35 years old
  • American Society of Anaesthesiologists (ASA) physical status I or II
  • Surgical removal of three to four wisdom teeth
  • general anaesthesia
  • Ambulatory surgery

Exclusion criteria

  • Obesity (Body mass index > 30 kg.m-²)
  • Pregnancy
  • Contraindication for nitrous oxide inhalation
  • Patient refusal

Treatment and study plan

Remifentanil

Drug

Wisdom teeth removal under general anaesthesia is usually suitable for ambulatory surgery.

The choice of opioid in dental day surgery is based on the need for a rapid and full recovery, as well as less morphine administration. Whether remifentanil can achieve these goals remains to be proved, especially regarding remifentanil-induced hyperalgesia, the potential prolonged Post Anesthesia Care Unit (PACU) stay, or remifentanil-induced workload for nurses.

Primary outcomes

  1. Morphine consumption in Post Anaesthesia Care Unit ( with intravenous titration given by nurse)

    Time frame: 48 h after the surgery

Secondary outcomes

  1. - Postoperative pain (measured by the numeric pain intensity scale)

    Time frame: 48 h after the surgery

  2. patient's satisfaction

    Time frame: 48 h after the surgery

  3. Length of stay in Post Anaesthesia Care Unit and in ambulatory surgery unit

    Time frame: 48 h after the surgery

  4. - Occurrence of postoperative nausea and vomiting

    Time frame: 48 h after the surgery

  5. additional workload for nurses

    Time frame: 48 h after the surgery

  6. postoperative analgesic requirement in the first 48 hours after surgery

    Time frame: 48 h after the surgery

  7. percentage of Glottic opening (POGO) score, Cormack-Lehane grading

    Time frame: 48 h after the surgery

  8. tolerance of the procedure

    Time frame: 48 h after the surgery

Sponsors and collaborators

Lead sponsor

University Hospital, Clermont-Ferrand

Other

Registry information

Acronym: SUF-REM-DDS

Important dates

Study start
2010
Primary completion
2011
Study completion
2011
First posted
Jun 8, 2010
Registry last updated
Jul 8, 2014

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.